ONLINE SUPPLEMENTARY APPENDIX. Webtable 1: Survey facilities random sampling
|
|
|
- Ursula Griffin
- 5 years ago
- Views:
Transcription
1 ONLINE SUPPLEMENTARY APPENDIX Webtable 1: Survey facilities random sampling Delhi, also known as the National Capital Territory (NCT) of Delhi, is divided into total 11 districts namely New Delhi, North Delhi, North West Delhi, West Delhi, South West Delhi, South Delhi, South East Delhi, Central Delhi, North East Delhi, Shahdara, and East Delhi. Out of these 11 districts, we selected a systematic random sample of eight survey districts. In each of the selected districts, a public sector hospital was selected as survey anchor (mentioned below). List of the survey districts and public-sector survey anchor hospital facilities Survey districts Public-sector survey anchor hospital facilities (location) 1 New Delhi Ram Manohar Lohia hospital (President's Estate) 2 East Delhi Lal Bahadur Shastri hospital (Khichripur) 3 North West Delhi Dr. Baba Saheb Ambedkar hospital (Rohini) 4 West Delhi Acharya Shree Bhikshu hospital (Moti Nagar) 5 South Delhi Madan Mohan Malviya hospital (Malviya Nagar) 6 South West Delhi Rao Tula Ram Memorial hospital (Jaffarpur Kalan) 7 Central Delhi Govind Ballabh Pant hospital (Jawaharlal Nehru Marg) 8 North East Delhi Jag Pravesh Chandra hospital (Shastri park) Note: The list of all the district-specific public-sector hospitals in Delhi state (sampling pool) was obtained from the Government of Delhi website 1 1
2 Figure: Map indicates the surveyed private-sector retail pharmacies (colored pins) in each of the eight districts. This map is generated based on the GPS coordinates collected at the site of surveyed retail pharmacy. The dark gray outline roughly marks the borders of the Delhi state, India. 2
3 Webtable 2. Public-sector insulin procurement prices (USD) Insulin Procurement price per 100 IU 10 ml vial (USD) Health department (year) Price source Soluble insulin; 40 IU/ml Government of NCT of Delhi 2014 Colleagues at local university Soluble insulin; 40 IU/ml Government of NCT of Delhi 2013 Colleagues at local university Soluble insulin; 40 IU/ml Municipal Corporation of Delhi Colleagues at local university (MCD) 2013 Soluble insulin (Human insulin R); 40 IU/ml Municipal Corporation of Delhi 2013 MCD Price booklet Soluble insulin (Human Government of NCT of Delhi 2013 Lok Nayak hospital e-tender insulin R); 40 IU/ml Soluble insulin (Human Government of NCT of Delhi 2013 Lok Nayak hospital e-tender insulin R) 100 IU/ml Biphasic isophane 30/ Government of NCT of Delhi 2014 Colleagues at local university insulin; 40 IU/ml Biphasic isophane 30/70 insulin; 40 IU/ml Government of NCT of Delhi 2014 Colleagues at local university Biphasic isophane 30/70 insulin; 40 IU/ml Municipal Corporation of Delhi 2013 MCD Price booklet Biphasic isophane 30/ Government of NCT of Delhi 2013 Lok Nayak hospital e-tender insulin; 40 IU/ml Biphasic isophane 30/70 insulin; 40 IU/ml Government of NCT of Delhi 2013 Baba Saheb Ambedkar hospital online documents Human insulin 50/50; Central government (2013) Colleagues at local university IU/ml Human insulin 50/50; 100 IU/ml Central government (2013) Central government rate contract Public-sector procurement prices refer to the price at which the government or public-sector hospitals procured insulin. We obtained these prices from colleagues at a local university and also performed web searches to find public-sector medicine procurement and rate contract documents uploaded on governments and hospitals websites. 3
4 Webtable 3: List of insulin listed in 2013 Delhi s essential medicine list Insulin molecule Insulin Soluble (Human) Insulin NPH (Human) Insulin Premixed (Human) 30%/70% Insulin Premixed (Human) 30%/70% Insulin Glargine (Human) Insulin Lispro / Apart / Inj. Glulisine Strength 40 IU/ml 40 IU/ml 40 IU/ml 100 IU/ml 100 IU/ml 100 IU/ml Webtable 4. Availability of insulin in retail pharmacies in Delhi state by type, delivery device and place of company s corporate headquarters Insulin type and delivery Place of company s corporate headquarters device Indian Foreign Combined (both Indian and foreign) Percent availability (n) Percent availability (n) Percent availability (n) 25.0% (10) 90.0% (36) 90.0% (36/40) Human insulin (All molecules) Vial 40 IU/ml 20.0% (8) 77.5% (31) 77.5% (31) 100 IU/ml 0.0% (0) 15.0% (6) 15.0% (6) Cartridge 40 IU/ml 0.0% (0) 2.5% (1) 2.5% (1) 100 IU/ml 7.5% (2) 25.0% (9) 25.0% (9) Pen 40 IU/ml 0.0% (0) 0.0% (0) 0.0% (0) 100 IU/ml 0.0% (0) 22.5% (4) 22.5% (4) Analogue insulin (All 5.0% (2/40) 32.5% (13/40) 32.5% (13) molecules) Vial 40 IU/ml 0.0% (0) 0.0% (0) 0.0% (0) 100 IU/ml 0.0% (0) 0.0% (0) 0.0% (0) Cartridge 40 IU/ml 0.0% (0) 0.0% (0) 0.0% (0) 100 IU/ml 5.0% (2) 17.5% (7) 17.5% (7) Pen 40 IU/ml 0.0% (0) 0.0% (0) 0.0% (0) 100 IU/ml 0.0% (0) 22.5% (9) 22.5% (9) 4
5 Webtable 5: Occurrence of insulin (any brand or company) in the private-sector market in Delhi state, India Insulin type Molecule description Strength Brand (company) Occurrence Human insulin Soluble insulin 40 IU/ml* Actrapid HM (Novo 40.0% (16) Huminsulin NPH (Lilly) 7.5% (3) Huminsulin R (Lilly) 7.5% (3) Wosulin R (Wockhardt) 5.0% (2) Human Actrapid (Novo 2.5% (1) Human Actrapid (Novo 2.5% (1) Lupisulin (Lupin) 2.5% (1) 100 IU/ml Huminsulin R (Lilly) 5.0% (2) Actrapid HM (Novo 5.0% (2) Human Actrapid (Novo 2.5% (1) Isophane insulin 40 IU/ml* Human Insultard (Novo 17.5% (7) Huminsulin NPH (Lilly) 12.5% (5) Huminsulin N (Lilly) 2.5% (1) 100 IU/ml Huminsulin N (Lilly) 2.5% (1) Huminsulin NPH (Lilly) 2.5% (1) Human Insultard (Novo 2.5% (1) Biphasic isophane 40 IU/ml* Human Mixtard (Novo 50% (20) insulin: 30% soluble insulin 70% isophane Huminsulin 30/70 (Lilly) 40.0% (16) insulin Insugen 30/70 (Biocon) 7.5% (3) 100 IU/ml* Lupisulin M30 (Lupin) 5.0% (2) Wosulin 30/70 (Wockhardt) 5.0% (2) Insucare M30 (Ranbaxy) 2.5% (1) Huminsulin 30/70 (Lilly) (9) Mixtard 30 HM (Novo 20.0% (8) Human Mixtard (Novo 5.0% (2) Mixtard 30 (Novo 5.0% (2) Lupisulin M30 (Lupin) 5.0% (2) 5
6 Biphasic isophane insulin: 50% soluble insulin 50% isophane insulin Wosulin 30/70 (Wockhardt) 5.0% (2) Mixtard 30 Flexpen (Novo 2.5% (1) 40 IU/ml Human Mixtard 50 (Novo 15.0% (6) Huminsulin 50/50 (Lilly) 7.5% (3) Insugen 50/50 (Biocon) 7.5% (3) 100 IU/ml Mixtard 50 HM (Novo 5.0% (2) Analogue insulin Insulin aspart 100 NovoRapid (Novo 12.5% (5) IU/ml* Biphasic insulin aspart: 30% insulin aspart & 100 IU/ml Novo Mix 30 (Novo 15.0% (6) 70% protamine crystallized aspart Biphasic insulin aspart: 50% insulin aspart & 100 IU/ml Novo Mix 30 (Novo 2.5% (1) 50% protamine crystallized aspart Insulin glargine 100 Lantus Solostar (Sanofi) 15.0% (6) IU/ml* Lantus (Sanofi) 7.5% (3) Basugine (Lupin) 5.0% (2) Insulin glulisine 100 Apidra Solostar (Sanofi) 2.5% (1) IU/ml* Apidra (Sanofi) 2.5% (1) Insulin lispro 100 Humalog (Lilly) 5.0% (2) IU/ml* Insulin lispro biphasic injection: 25% insulin 100 IU/ml Humalog Mix 25 (Lilly) 12.5% (5) lispro 75% lispro protamine Insulin lispro biphasic injection: 50% insulin 100 IU/ml Humalog Mix 50 (Lilly) 12.5% (5) lispro 50% lispro protamine Mean availability of human insulins listed on 2013 Delhi essential medicine list Mean availability of analogue insulin listed on 2013 Delhi essential medicine list * Insulins listed on the 2013 Delhi essential medicines list 6
7 Webtable 6. Median consumer prices (US dollars) of 10 ml 100IU/ml insulin, by place of company s corporate headquarters and combined Combined (company of any origin) Median consumer price (1) Indian company Median consumer price (2) Foreign company Median consumer price (3) p-value (4) Human insulin Vial USD 5.6 USD 5.6 USD * Cartridge USD 11.2 USD 8.1 USD Pen USD 18.5 # USD Analogue insulin Vial # # # -- Cartridge USD 24.9 USD 26.4 USD Pen USD 32.8 # USD 70.1 Webtable 7: Affordability of insulin in Delhi state, India Median unit 100 IU Per capita 10ml vial cost (overall: cost of company of any monthly origin) insulin supply (~ 1.2 vials or 1200 IU) Human Vial Rs Rs USD 5.6 USD 6.78 Human Cartridge Rs Rs USD 11.2 USD Human Pen Rs Rs USD 18.5 USD Analogue Vial # Analogue Cartridge Rs USD Rs USD Ratio (monthly per capita insulin cost compared to India s per capita monthly health spending) Number of days per month an unskilled lowest worker will have to work to pay for his or child s (Type 1 diabetes) monthly insulin supply Analogue Pen Rs Rs USD 32.8 USD The prices (collected in Indian Rupees) of all survey insulin products with variable pack sizes (milliliters) and strength were adjusted to 10 ml 100 IU/ml pack for purpose of comparisons. Per capita monthly insulin need is calculated based on WHO daily defined dose of 40 IU/day. The wage of a lowest paid unskilled worker during the time of survey was Rs per month (i.e. daily wage of Rs ). 2 The 2013 annual per capita health expenditure (both public and private sectors combined) was USD 69.0 (Rs. 4,275.9) i.e. monthly USD 5.74 (Rs ). 3 7
8 Webtable 8: Price components of the internationally manufactured (imported) insulin products found in the privatesector market in Delhi state Insulin Product brand Country of Package Percentage mark-ups molecule (company) Manufacture form Import to Wholesale Import to [Number of wholesale to consumer products found price (per consumer price (per in facility ml) price (per ml) survey] ml) Human insulin Soluble insulin 100 IU/ml [3] Isophane insulin 100 IU/ml [3] Biphasic isophane insulin: 30% sol 70% isophane 100 IU/ml [5] Biphasic isophane insulin: 50% sol 50% Huminsulin R (Lilly) Egypt Vial 16.72% 18.76% 38.62% Human Actrapid (Novo Brazil Cartridge 26.95% 19.34% 51.50% Human Actrapid (Novo Denmark Pen ** 16.57% ** Huminsulin N (Lilly) Egypt Vial 14.90% 18.74% 36.43% Huminsulin NPH (Eli France Cartridge 16.73% 17.64% 37.33% Lilly) Human Insultard (Novo Brazil Cartridge 14.46% 24.87% 42.93% Human Mixtard (Novo Denmark Vial ** 22.52% ** Huminsulin 30/70 Egypt Vial 11.18% 24.96% 38.94% (Lilly) Huminsulin 30/70 (Eli France Cartridge 16.21% 24.43% 44.61% Lilly) Mixtard 30 HM (Novo Brazil Cartridge 33.41% 16.06% 54.83% Mixtard 30 HM (Novo Denmark Pen 27.23% 24.55% 58.46% Mixtard 50 HM (Novo Denmark Cartridge 26.46% 19.34% 50.92% 8
9 isophane 100 IU/ml [1] Analogue insulin Insulin Aspart 100 IU/ml [1] Biphasic insulin aspart: Insulin Aspart & Protamine crystallized Aspart 30/70; 100 IU/ml [1] Biphasic insulin aspart: Insulin Aspart & Protamine crystallized Aspart 50/50; 100 IU/ml. [1] Insulin glargine 100 IU/ml [3] Insulin glulisine 100 IU/ml [2] Insulin lispro 100 IU/ml [1] Insulin Lispro Biphasic injection: 25% insulin lispro Novo Rapid (Novo Denmark Pen 20.71% 24.87% 50.73% Novo Mix 30 (Novo Brazil Cartridge 25.84% 13.98% 43.43% Novo Mix 30 (Novo Novo Mix 50 (Novo Brazil & Pen 8.44% 24.83% 35.37% Denmark Denmark Pen 15.98% 31.0% 51.99% Lantus (Sanofi-Aventis) Germany Cartridge 11.47% 29.40% 44.24% Basugine (Lupin) China Cartridge 74.68% 30.85% % Lantus Solostar (Sanofi- Aventis) Germany Pen ** 82.48% ** Apidra (Sanofi-Aventis) Germany Cartridge ## ## 41.26% Apidra Solostar (Sanofi- Germany Pen ## ## 43.73% Aventis) Humalog (Eli Lilly ) Italy Cartridge 5.31% 19.07% 25.40% Humalog Mix (Eli Lilly) Italy & USA Cartridge 6.20% 24.46% 32.17% Humalog Mix 25 (Eli USA Pen ** 19.20% ** Lilly) 9
10 75% lispro protamine; 100 IU/ml [2] Insulin Lispro Humalog Mix 50 (Eli France & Cartridge 6.22% 22.04% 29.63% Biphasic injection: 50% Lilly) Humalog Mix 50 (Eli USA USA Pen 5.23% 19.20% 25.43% insulin lispro Lilly) 50% lispro protamine; 100 IU/ml [2] Median (Min; Human insulin 16.77% 19.34% 43.77% Max) (11.18%; (16.06%; (36.43; percentage 33.41%) 25.0%) 58.46) mark up Analogue insulin 9.96 (5.29; 74.68) (13.98; 82.48) (16.49; ) ** Import price not available; ## Available price data point was higher than the succeeding supply chain price point. In other words, either import or wholesale price was higher than wholesale or consumer price, respectively. References: 1. Health and family Welfare, Government of NCT of Delhi. [District-wise list of publicsector hospitals] Accessed on 6 June, delhi+govt.+hospitals 2. Minimum wages revised in Delhi w.e.f. 01st Apr Labor Law Reporter. Accessed on 6 June, Data: Health expenditure per capita (current US$). World Bank. Accessed on 6 June,
Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins
Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,
Median price ratio of salbutamol inhaler 0.1mg/dose
Median price ratio of salbutamol inhaler Median price ratio* (MPR) Countries by WHO Region Private Public Procurement Originator Generic Originator Generic Originator Generic 3.32 0.92 3.12 1.92 2.37 2.94
Drug Effectiveness Review Project Summary Report Long acting Insulins
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
8/13/2016. Insulin Basics. Rapid-Acting Insulin Analogs. Current Insulin Products and Pens. Basal Insulin Analogs. History of Insulin Therapy
Insulin Basics Anabolic hormone involved in metabolism Following carbohydrate ingestion insulin release is stimulated Suppresses hepatic glucose production Stimulates peripheral glucose uptake Commercially-available
ClinicalTrials.gov Identifier: sanofi-aventis. Sponsor/company:
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinicalTrials.gov
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015 S. No. Firm Name of Formulation Registration Certificate No. & Validity 1. M/s. Nirlac Chemicals,14 th
Insulin Prior Authorization with optional Quantity Limit Program Summary
Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) June 2017 Review: June 2020 (earlier if required see recommendations) Bulletin 255: Insulin aspart New Formulation - Fiasp JPC Recommendations:
Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children
Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children December 2008 This technology summary is based on information available at the time of research and a limited literature
PRAC recommendations on signals
18 May 2017 EMA/PRAC/252869/2017 Pharmacovigilance Risk Assessment Committee (PRAC) Adopted at the 2-5 May 2017 PRAC meeting This document provides an overview of the recommendations adopted by the Pharmacovigilance
PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES
PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages
Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s
Premixed Insulin for Type 2 Diabetes a gu i d e f o r a d u lt s March 2009 What This Guide Covers / 2 Type 2 Diabetes / 3 Learning About Blood Sugar / 4 Learning About Insulin / 5 Comparing Medicines
Kyrgyzstan. Medicine prices, availability, affordability & price components
Kyrgyzstan Medicine prices, availability, affordability & price components Medicine prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially
Insulin for Adults with Type 2 Diabetes
rth Central London Joint Formulary Committee Insulin for Adults with Type 2 Diabetes Disclaimer This guideline is registered at rth Central London (NCL) Joint Formulary Committee (JFC) and is intended
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016
1. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India 2. M/s Eli Lilly and Co (I) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1 st Fl, Arihant Comm. Complex,
Objectives. Navigating New Insulins. Disclosures. Diabetes: The Stats. Normal Insulin Release Individuals without diabetes. History of Insulin 5/23/17
Objectives Compare and contrast currently available products. Navigating New s Diana Isaacs, PharmD, BCPS, BC-ADM, CDE Clinical Pharmacy Specialist Cleveland Clinic Diabetes Center Determine the factors
Converting lantus to humalog 75 25
P ford residence southampton, ny Converting lantus to humalog 75 25 This page includes the following topics and synonyms: Insulin Dosing in Type 2 Diabetes, Insulin Dosing in Type II Diabetes. Thiazide
Insulins: Prices, Rebates, and Other Factors Influencing Costs. May 2018
Insulins: Prices, Rebates, and Other Factors Influencing Costs May 2018 Introduction: Types of Insulin Types of Insulin Rapid-acting: Usually taken before a meal to cover the blood glucose elevation from
What is shelf life of lantus
What is shelf life of lantus Search 6-6-2011 I've been told Lantus looses some of it's effectiveness after 30. Levemir has a 42 day shelf life after opening. 5 Reasons to Join Diabetic Connect;. Lantus
INSULIN 101: When, How and What
INSULIN 101: When, How and What Alice YY Cheng @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form
PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES
PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages
Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices
Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices Authors: Jean Fuglesten Biniek William Johnson January 2019 Insulin Prices Were the Primary Driver of Rapid
Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes
Types of Insulin Rapid-acting insulin: lispro (Humalog), aspart (NovoRapid), glulisine (Apidra) Regular short-acting insulin: Humulin R, Novolin ge Toronto, Hypurin Regular Basal insulin: NPH (Humulin
Drug Use Criteria: Exogenous Insulin Products
Texas Vendor Program Use Criteria: Exogenous Products Publication History 1. Developed June 2017. Notes: Information on indications for use or diagnosis is assumed to be unavailable. All criteria may be
Tunisia. Medicine prices, availability, affordability and price components. Medicine prices matter. Tunisia
prices, availability, affordability and price components prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing and transitional
Exogenous Insulin in type 2 DM
Exogenous Insulin in type 2 DM Russell Scott 2015 Part 1: Some basic biochemistry for Insulin absorption and action MY CHECK LIST Factors influencing insulin action: Forgets to inject Amount given Timing
Shanghai. China. Medicine prices, availability and affordability
Shanghai China Medicine prices, availability and affordability Medicine prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing
Iraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001
nam origmanufacturer nammanufacturer National code Mousel Scientific Iraq NDI Iraq 04-J00-042 Sandoz GmbH Austria for Sandoz GmbH by Sandoz Ilac Sanayi ve India 05-AH0-040 France Famar Lyon France 05-D00-024
INSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min.
INSULIN OVERVIEW Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro Humalog 15-30 min 30-90 min 3-5 hrs aspart glulisine Short-Acting Regular insulin NovoLog Apidra
DBA Design Effectiveness Awards SoloSTAR. A disposable pen injector for insulin
DBA Design Effectiveness Awards 2009 SoloSTAR A disposable pen injector for insulin Category: Sub category: Client company: Design consultancy: Product Consumer Sanofi Aventis GmbH DCA Design International
China Insulin Industry Report, Jan. 2011
China Insulin Industry Report, 2010 Jan. 2011 This report analyzes the status, competition pattern and development direction of the insulin industry Focuses on the operation and development prospect of
24 Hour Support. Telephone Available 24 hours a day, 7 days a week
Contents Page What is SHAIRE? 1 What is basal-bolus regimen? 2 Why do I need a basal-bolus regimen? 3 How does basal insulin work? 3 How does rapid-acting insulin work? 4 How often should I test my Blood
PRINCIPLES OF INSULIN THERAPY
08 PRINCIPLES OF INSULIN THERAPY 8.1 GENERAL PRINCIPLES 8.1.1 Indications of Insulin Therapy The classical type 1 diabetes mellitus and LADA cases Hyperglycemic emergencies (DKA, HHS) Some cases of type
Sunderland Diabetes Network - Recommendations for safe prescribing of insulin.
Sunderland Diabetes Network - Recommendations for safe prescribing of insulin. Note: High strength insulins and biosimilar insulins are for specialist initiation only. They should not be initiated in primary
Guide for Storage of Insulin
Guide for Storage of Insulin Every effort is made to assure the accuracy of the attached information. This information is not intended to be used as a tool to prescribe medication or provide other clinical
VOLUNTARY COMPLIANCE UNDERTAKING OF ELI LILLY CANADA INC. TO THE PATENTED MEDICINE PRICES REVIEW BOARD
1. Product Summary VOLUNTARY COMPLIANCE UNDERTAKING OF ELI LILLY CANADA INC. TO THE PATENTED MEDICINE PRICES REVIEW BOARD 1.1_ 1.2_ 1.3_ 1.4_ 1.5_ Humalog 100 unit/ml vials (DIN 2229704) and Humalog 100
Legal Status Indication Treatment of Type 1 and Type 2 diabetes
New Medicine Report (Adopted by the CCG until review and further notice) Document Status Recombinant human insulin analogues Following Suffolk D&TC Meeting Traffic Light Decision Green Date of Last Revision
Sunderland Diabetes Network - Recommendations for safe prescribing of insulin.
Sunderland Diabetes Network - Recommendations for safe prescribing of insulin. Note: High strength insulins and biosimilar insulins are for specialist initiation only. They should not be initiated in primary
Current Challenges & Constraints
Access to insulin Current Challenges & Constraints October 2015 2 Access to insulin Current Challenges & Constraints October 2015 David Beran Geneva University Hospitals and University of Geneva Margaret
Temporary interruption in supply of APIDRA (insulin glulisine) - OPTISET and SOLOSTAR prefilled pens and CLIKSTAR reusable cartridges.
September 2011 Dear Health Care Professional, Temporary interruption in supply of APIDRA (insulin glulisine) - OPTISET and SOLOSTAR prefilled pens and CLIKSTAR reusable cartridges. We would like to inform
Islamic Republic of Iran
Islamic Republic of Iran prices, availability, affordability and price components prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially
Iso-Insulin ELISA ( ), Brochure
Iso-Insulin ELISA (10-1128-01), Brochure Interest in any of the products, request or order them at Bio-Connect Diagnostics. Bio-Connect Diagnostics B.V. T NL +31 (0)26 326 44 60 T BE +32 (0)2 502 12 53
Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research "Type 1 diabetes market size was valued at USD 25.52 billion in 2016 and is expected to exhibit rewarding
Egypt. Prices and affordability of medicines to treat noncommunicable
Egypt Prices and affordability of medicines to treat noncommunicable diseases Medicine prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially
Kuwait. Medicine prices, availability, affordability and price components. Medicine prices matter
prices, availability, affordability and price components prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing and transitional
4/2/2018. Easing the pharmacy experience and stretching the diabetes dollar. Alyson Blum, PharmD, CDE. I have no conflicts of interest to disclose
Easing the pharmacy experience and stretching the diabetes dollar. Alyson Blum, PharmD, CDE Clinical Pharmacist in Obstetrics Center for Maternal Fetal Medicine at Sacred Heart Medical Center Clinical
Tips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital
Tips and Tricks for Starting and Adjusting Insulin MC MacSween The Moncton Hospital Progression of type 2 diabetes Beta cell apoptosis Natural History of Type 2 Diabetes The Burden of Treatment Failure
International Operations overview and strategy. Maziar Mike Doustdar EVP International Operations. Slide 1
Slide 1 International Operations overview and strategy Maziar Mike Doustdar EVP International Operations KUALA LUMPUR Home of International Operations Business Area Southeast Asia Slide 2 Forward-looking
Commercial insulin immunoassays fail to detect commonly prescribed insulin analogues
Commercial insulin immunoassays fail to detect commonly prescribed insulin analogues Ceri Parfitt Trainee Clinical Scientist Blood Sciences Department Royal Devon and Exeter NHS Foundation Trust November
Country Health SA Local Health Network Protocol Subcutaneous Insulin Administration in the Community Setting
1. Rationale Correct supervision and/or administration and documentation of subcutaneous insulin for diabetes management. Promote independence towards self or assisted administration of insulin and blood
Managing your diabetes: Travel Advice
Managing your diabetes: Travel Advice Information for patients, relatives and carers For more information, please contact: Your diabetes team on telephone number 01904 726510 The York Hospital Wigginton
Comparison of the Dose Accuracy of Prefilled Insulin Pens
Journal of Diabetes Science and Technology Volume 3, Issue 1, January 2009 Diabetes Technology Society ORIGINAL ARTICLES Comparison of the Dose Accuracy of Prefilled Insulin Pens Alexander, M.Sc., Johannes
Mixed Insulins Pick Me
Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing
Policies and approaches to increase access essential medicines to treat major NCDs in both public and private facilities
Policies and approaches to increase access essential medicines to treat major NCDs in both public and private facilities Prof RohiniFernandopulleMBBS (Cey),PhD, FCGP(SL) Clinical Pharmacologists Sir John
Dose Accuracy of the ClikSTAR, NovoPen 4, and Luxura Insulin Pens: Results of Laboratory and Field Studies
Journal of Diabetes Science and Technology Volume 5, Issue 5, September 2011 Diabetes Technology Society ORIGINAL ARTICLE Arnd, Ph.D., 1 Nils Basso, Ph.D., 2 and Steffen Adler, Ph.D. 1 Abstract Background:
Insulin Pens - Medical Devices Pipeline Assessment, 2016
Insulin Pens - Medical Devices Pipeline Assessment, 2016 Insulin Pens - Medical Devices Pipeline Assessment, 2016 Sector Publishing Intelligence Limited (SPi) has been marketing business and market research
Mediscor Medicines Review 2011
Mediscor Medicines Review 2011 Mediscor Client Workshop 2012 28 August 2012 Presented by: Madelein Bester Benefit Management Mediscor PBM Content Background of the report Overall trends Expenditure per
Diabetes Care Publish Ahead of Print, published online June 1, 2009
Diabetes Care Publish Ahead of Print, published online June 1, 2009 Biphasic insulin aspart 30/70 (BIAsp 30): pharmacokinetics (PK) and pharmacodynamics (PD) in comparison with once-daily biphasic human
A Fact Sheet for Parents and Carers Insulin and Diabetes
A Fact Sheet for Parents and Carers Insulin and Diabetes In type 1 diabetes the body stops producing insulin. Insulin therapy is essential in the treatment of type 1 diabetes, together with a healthy eating
How to Fight Diabetes and Win. Diabetes. Medications
How to Fight Diabetes and Win Diabetes Medications MEDICATIONS FOR DIABETES According to the American Diabetes Association, 85% of adults diagnosed with diabetes take insulin and/or oral medication to
Insulin Management and Advancing Practice of the Registered Dietitian Nutritionist (RDN) in Diabetes Care
Insulin Management and Advancing Practice of the Registered Dietitian Nutritionist (RDN) in Diabetes Care Patricia Davidson, DCN, RDN, CDE, LDN, FAND West Chester University of Pennsylvania West Chester,
BC PharmaCare Newsletter
BC PharmaCare ewsletter August 24, 2010 Edition 10-009 Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers QuickLinks Pharmacy Services
Disclosures. Learning Objectives 4/26/2017
Implementation of a quality improvement initiative to ensure the safe transition from prior-to-admission concentrated insulins to a formulary insulin regimen ERICA J. RHEIN, PHARMD PGY1 PHARMACY PRACTICE
Sponsor / Company: Sanofi Drug substance(s): Insulin Glargine. According to template: QSD VERSION N 4.0 (07-JUN-2012) Page 1
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
Past, Present and Future of Diabetes
Past, Present and Future of Diabetes Dr Ketan Dhatariya Consultant in Diabetes Norfolk and Norwich University Hospital NHS Trust To Begin With, Some History διαβήτης to stand apart or a a siphon first
Global Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast ( )
Global Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast (2017-2022) Analysis By Type - Fresh/Dried leaves, Stevia powder,
Diabetes Head to Toe May 31, 2017
Innovations in Insulin Joanne Reid RN CDE jmreid@gbhs.on.ca Danielle Benedict RPh Outline Setting the stage Insulin as pancreas replacement therapy Commonly used insulins New insulins Case Studies Dosing
Insulin Management. By Susan Henry Diabetes Specialist Nurse
Insulin Management By Susan Henry Diabetes Specialist Nurse The Discovery of Insulin - 1921 - Banting & Best University Of Toronto Discovered hormone insulin in pancreatic extract of dog - Marjorie the
Country Coverage. Company Coverage
Global Heart Valve Devices Market: Analysis By Procedure (Replacement & Repair), Replacement Procedure By Technique (Mechanical, Bioprosthetic & TAVR), Repair Procedure By Technique (Surgical, Balloon
Abstract. Introduction
Journal of Diabetes Science and Technology Volume 5, Issue 5, September 2011 Diabetes Technology Society ORIGINAL ARTICLE FlexTouch: A Prefilled Insulin Pen with a Novel Injection Mechanism with Consistent
EADSG Guidelines: Insulin Therapy in Diabetes
Diabetes Ther (2018) 9:449 492 https://doi.org/10.1007/s13300-018-0384-6 GUIDELINES EADSG Guidelines: Insulin Therapy in Diabetes Bahendeka Silver. Kaushik Ramaiya. Swai Babu Andrew. Otieno Fredrick. Sarita
Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products
Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products FDA LABELED INDICATIONS 1-13,16-21 Rapid-Acting Indication Onset Peak Duration Insulins Admelog (insulin
Type I Type II Insulin Resistance
Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100
Insulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products
Insulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products FDA LABELED INDICATIONS 1-13,16-20 Rapid-Acting Indication Onset Peak Duration Insulins Fiasp (insulin
Insulin Basic facts. Patient Education Patient Care Services. What is insulin? What types of insulin are there? Basal Insulin
Patient Education Insulin Basic facts Insulin is a protein made by the pancreas that allows your cells to use glucose for energy. There are different types of insulin: Basal long-acting insulin that controls
Comparative Storage and Utilization Analysis of Insulin Across Inpatient Hospital Settings
Comparative Storage and Utilization Analysis of Insulin Across Inpatient Hospital Settings Tristan A. Moorman PharmD/ MPA Candidate 2017 University of Kentucky College of Pharmacy Martin School of Public
Basal-Bolus Insulin Therapy. Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January
Basal-Bolus Insulin Therapy Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January 18 2018 Terminology No longer using the term diabetic. Diabetes does not define people. People with diabetes are individuals
ACCESS TO INSULIN: CURRENT CHALLENGES AND CONSTRAINTS
ACCESS TO INSULIN: CURRENT CHALLENGES AND CONSTRAINTS Update March 2017 11 ACCESS TO INSULIN FACT SHEET ACCESS TO INSULIN: CURRENT CHALLENGES AND CONSTRAINTS 12 Update March 2017 ACCESS TO INSULIN FACT
ADMELOG, NOVOLIN, NOVOLOG, and FIASP
ADMELOG, NOVOLIN, NOVOLOG, and FIASP Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS
TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS The aim of the Diabetes level 2 service is to provide a high quality service for safe initiation and optimization of injectable therapy within GP networks.
Sponsor / Company: Sanofi Drug substance(s): Insulin Glargine (HOE901) Insulin Glulisine (HMR1964)
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
Basal Insulin Drug Class Prior Authorization Protocol
Basal Insulin Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review of medical
EASD European Association for the Study of Diabetes
Insulin analogues and cancer: a possible link that needs further investigation Diabetologia, the journal of the (EASD), has just published a series of research papers that have examined a possible link
Opinion 18 December 2013
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 18 December 2013 LANTUS 100 units/ml, solution for injection in a vial B/1 vial of 10 ml (CIP: 34009 359 464 9 2)
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
Medicine Prices, Availability, Affordability in Kyrgyz Republic
Medicine Prices, Availability, Affordability in Kyrgyz Republic Report of a survey conducted September to October 2015 23 November, 2015 MeTA Project in Kyrgyzstan (Medicines Transparency Alliance) Bishkek
Hypoglycemics, Lantus Insulin
Texas Prior Authorization Program PDL Edit Criteria Drug/Drug Class Hypoglycemics, Lantus Insulin Information Included in this Document Hypoglycemics, Lantus Insulin Drugs requiring prior authorization:
Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin
Open Access To cite: Holden SE, Poole CD, Morgan CL, et al. Evaluation of the incremental cost to the National Health Service of prescribing insulin. BMJ Open 2011;1:e000258. doi:10.1136/bmjopen-2011-000258
SAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB
Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product
What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin
Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team
Govt. of NCT of Delhi OFFICE OF THE CHIEF SECRETARY Delhi Secretariat. J.P. Estate, New Delhi. CIRCULAR
Govt. of NCT of Delhi OFFCE OF THE CHEF SECRETARY Delhi Secretariat. J.P. Estate, New \ S"_ b2- - \..0 t0 F.No.1 0(21 )/2007/T/Part-l/ t b ~'3. Dated: 10.02.2010 CRCULAR 1. The web-portal of Delhi Government
Initiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital
Initiating Injectables in Type 2 Diabetes Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital Increasing levels in delivery of diabetes care Complex Care support 3 3.1 People with diabetes
Sponsor / Company: Sanofi Drug substance(s): Insulin Glargine (HOE901) Insulin Glulisine (HMR1964)
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
PRESCRIBING INCENTIVE SCHEME 2018/19
PRESCRIBING INCENTIVE SCHEME 2018/19 Summary Harrogate and Rural District CCG is continuing to offer a prescribing incentive scheme to all its member NHS GP practices as encouragement and reward to improve
Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,
The Global Alliance for Improved Nutrition
The Global Alliance for Improved Nutrition JCIE Seminar on Challenges in Global Health: New Opportunities for the Private Sector 27 July 2010, Tokyo 1 Outline Why Nutrition Matters About GAIN GAIN Nutrition
These results are supplied for informational purposes only.
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
Understanding Diabetes and Insulin Delivery Systems
Page 1 This program has been supported by an educational grant from Sanofi Aventis Scott K. Stolte, Pharm.D. Associate Dean, Academic Affairs Bernard J. Dunn School of Pharmacy Shenandoah University Winchester,
When I began working in diabetes,
P r a c t i c a l p o i n t e r s Clinicians Guide to Diabetes Gadgets and Gizmos Anne W. Brown, MSN, BC-ADM, BC-ANP When I began working in diabetes, the first blood glucose meter had just been released.
DIABETES INDICATIONS FOR INSULIN
DIABETES INDICATIONS FOR INSULIN 1 Introduce the likely need for insulin in the future early on as part of patient education Emphasise that it is the pancreas that fails not the patient Assess if greater